Sign in: Staff/Students
Dinesh Bhugra CBE, Professor Saye Khoo, Katie McAllister and Alastair Campbell
Digital prescribing support resources developed by the University of Liverpool to help optimise treatment for HIV patients worldwide have won a national medical research award.
The British Medical Association (BMA) MEDFASH Prize is awarded in recognition of work that improves the quality of HIV and sexual healthcare in the UK. This year the Liverpool Drug Interactions team was selected as the winner of the Prize for its world leading HIV Drug Interactions resources.
Developed and maintained by researchers at the University’s Institute of Translational Medicine, http://www.hiv-druginteractions.org and companion app HIV iChart provide comprehensive, clinically-useful, evidence-based, drug interaction resources, which are freely available to healthcare workers, patients and researchers across the globe. The resource is recommended as a key patient management tool in multiple national, regional and international treatment guidelines, including those published by the British HIV Association, European AIDS Clinical Society and the World Health Organisation.
Constantly updated resource
While advances in therapy have yielded effective treatments, the drugs used to treat HIV are amongst the most therapeutically risky for drug-drug interactions (DDIs) which can cause significant patient harms. Many drug combinations have the potential to interact and this can affect patient safety or the effectiveness of treatment. For this reason, some drug combinations should not be given at all, while other drugs may be used together with caution. Managing potential drug interactions is an essential part of HIV clinical management and prescribers need access to regularly updated, evidence-based information in order to manage these treatment complexities safely and effectively.
The Liverpool applications and websites provide a guide to interactions that may occur between different HIV drugs and over 700 commonly prescribed co-medications, as well as recreational drugs and herbals. The resources are constantly updated to reflect the latest research and safety data and respond to over 300,000 interaction queries from over 20,000 users each month.
Katie McAllister, Development Manager, Molecular and Clinical Pharmacology, University of Liverpool, said: “Just a few months after Liverpool pharmacologists we awarded the Queens Anniversary Prize and were shortlisted for The British Medical Journal Awards, the University has again been recognised for our HIV pharmacological research by being selected as the recipient of this year’s BMA MEDFASH Prize.
“Our resources have a huge impact globally: use of the drug interaction checkers has become an integral part of HIV patient management in the UK and beyond: leading HIV clinicians regularly report what an essential tool it is to their daily practice. We know and are proud that our resources make clinicians’ lives easier, but it is a special honour to have the impact of our work on people living with HIV recognised in this way”
BMA Trustees, said: “The Liverpool HIV Drug Interactions Programme stands out for the scale of its impact across the UK and internationally. Over many years its impressive open access website and apps have been a vital resource for HIV doctors and pharmacists as well as for people living with HIV, and it continues to be an evolving bedrock of high quality HIV clinical care. Without the Liverpool HIV Drug Interactions Programme the world would be a much more hazardous place for every person with or at risk of HIV in the UK.”
Through the BMA Foundation, the BMA has been supporting medical research since 1839 and is the oldest medical organisation in the world to award grants and prizes to encourage further medical research. Thanks to the support of generous individuals, in 2018 eleven research grants totalling £575,000 will be awarded to winning applicants. The grants provide funding for a variety of different subject areas, ranging from research into rheumatism and arthritis, to cardiovascular disease, cancer and neurological disorders.
MEDFASH was an independent charity dedicated to improving the quality of HIV and sexual healthcare from 1987 to 2016. The vision of MEDFASH was for everyone who needed it to be able to receive high quality, evidence-based sexual health and HIV care, including preventive interventions.
To continue the legacy of MEDFASH, the BMA foundation awards an annual prize named after MEDFASH to an individual or organization exemplifying MEDFASH’s mission and values, which have been embedded in the prize assessment criteria.
This year’s prestigious awards ceremony was held last night [Tuesday, 6 November] at BMA House in central London and was presented by BMA President, Professor Dinesh Bhugra CBE.
For more information on how you can help to keep HIV drug interactions and its associated app HIV iChart up-to-date, comprehensive and freely available worldwide please click here.
You must be logged in to post a comment.
All recent news
Year of the Tiger: Celebrations for Lunar New Year 2022
Blog: How I will be celebrating Lunar New Year
New project to explore the ‘hidden world’ of proteins
Researchers confirm dog sickness outbreak in Yorkshire
Treasury minister quits over COVID loan fraud: what we know so far about the unfolding scandal
Tune in to @bbcmerseyside breakfast show tomorrow at around 8.05am to hear Artistic Director @richardhartwell talk about our launch season programme! https://twitter.com/bbcmerseyside/status/1487123308751593479
Researchers are set to harness ground-breaking technologies to explore the 'hidden world' of proteins.
@ClaireEEyers will work with @UniofOxford & @sangerinstitute on the project, which has won £5.5m @BBSRC funding.
@c4pr_liv @LivUniISMIB @KavliOxford https://news.liverpool.ac.uk/2022/01/28/new-project-to-explore-the-hidden-world-of-proteins/
You may have seen recent media reports of a 'mystery illness' affecting dogs in some parts of the UK.
Our @savsnet team has been monitoring the data & confirmed an outbreak of gastrointestinal disease in Yorkshire, although the cause is still unknown.